Friday, February 03, 2023 12:50:16 PM
COVID was scammed by Phiser/Fousi and even MDNA was pushed aside. All repurposed drugs from several companies were forced to do Trials while Phiser was given a pass and subsidized Trials/research. So inaccurate question IMO., but there are many articles on these subjects.
Ifenprodil did not fail it's CT and there were significant benefits proven including IL-6 for COVID patients and CC reduction / slowing rate of IPF in that 2nd Phase 2 CT for Ifenprodil. i.e. a Phase 2b CT for CC this summer/asap...
I would talk about Cancer But Cancer use for Ifenprodil is another repurposed direction still being applied for ODD/IND status at the FDA and a current CT is not being planned. Maybe later as with the CKD drug. So Yes.
...(I have discussed Cancer in private, confidentially, but I dislike malfeasant sour grapes, so that's over) ....!!
Accusing the AGN CEO of being a drunk is a TOS violation, IMHFO...
If you dont like the company;s format for repurposed drugs then sell the rest of any shares you may still have and move on. I plan to buy more.
Taking comments out of context, ie Shell, is unfair IMO.
You're Buddy...
...GLTA...
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM